+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antigen Presenting Cell"

CD40 Ligand Market - Global Forecast 2026-2032 - Product Thumbnail Image

CD40 Ligand Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
T Cell Specific Surface Glycoprotein CD28 Market Report 2025 - Product Thumbnail Image

T Cell Specific Surface Glycoprotein CD28 Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
4-1BB Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

4-1BB Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
From
Esophageal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
Gastric Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 550 Pages
  • Global
From
Acute Graft-versus-Host Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Graft-versus-Host Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2025 - Product Thumbnail Image

T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Anti-CD40 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD40 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Allergic Rhinitis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Allergic Rhinitis - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 130 Pages
  • Global
From
From
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
Pipeline of CD40 Agonists and CD40/L Antagonists - Product Thumbnail Image

Pipeline of CD40 Agonists and CD40/L Antagonists

  • Report
  • February 2026
  • Global
From
  • 18 Results (Page 1 of 1)
Loading Indicator

The Antigen Presenting Cell (APC) market is a subset of the Immune Disorders Drugs market. APCs are specialized cells that play a key role in the immune system by recognizing and presenting antigens to other cells of the immune system. APCs are used in the development of drugs for a variety of immune disorders, including autoimmune diseases, allergies, and cancer. APCs are also used in the development of vaccines, as they are able to recognize and present antigens to the immune system, triggering an immune response. The APC market is expected to grow in the coming years, driven by the increasing prevalence of immune disorders and the development of new treatments. Additionally, the increasing demand for personalized medicine is expected to drive the growth of the APC market. Some companies in the APC market include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, and Miltenyi Biotec. Show Less Read more